Direct Analysis By LC/MS Speeds Up Determination Of Potential Genotoxins In Pharmaceutical Drug Candidates
Direct Analysis By LC/MS Speeds Up Determination Of Potential Genotoxins In Pharmaceutical Drug Candidates
4 PagesAstraZeneca R&D Charnwood Loughborough, UK Success Story Direct analysis by LC/MS speeds up determination of potential genotoxins in pharmaceutical drug candidates This publication describes how the Process R&D Department at AstraZeneca, Loughborough, UK, deployed Agilent LC/MS equipment and a direct-injection approach to speed up the determination of potential genotoxins in pharmaceutical drug candidates. In this case study, AstraZeneca had two
